A5319312
LOXO-101 , 97% , 1223403-58-4
CAS NO.:1223403-58-4
Empirical Formula: C21H22F2N6O2
Molecular Weight: 428.44
MDL number: MFCD28902192
Pack Size | Price | Stock | Quantity |
5MG | RMB583.20 | In Stock |
|
10mg | RMB1055.20 | In Stock |
|
25mg | RMB1751.20 | In Stock |
|
50m | RMB3151.20 | In Stock |
|
50mg | RMB3151.20 | In Stock |
|
100MG | RMB5599.20 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Density | 1.55±0.1 g/cm3(Predicted) |
storage temp. | RT |
solubility | Soluble in DMSO (up to 5 mg/ml). |
form | solid |
pka | 8.41±0.40(Predicted) |
color | Yellow |
Stability: | Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 2 months. |
Description and Uses
LOXO-101 is an inhibitor of the tropomyosin-related kinases TrkA, TrkB, and TrkC (IC50s = 2-20 nM). It is selective for TrkA, -B, and -C over a panel of 226 kinases at 1 μM. LOXO-101 inhibits the growth of CUTO-3.29, KM12, and MO-91 patient-derived cancer cell lines (IC50s = <100, <10, and <10 nM, respectively). In vivo, LOXO-101 (60 and 200 mg/kg) reduces tumor growth in a KM12 mouse xenograft model.
Larotrectinib is a TRK Inhibitor (Tyrosine kinase inhibitor).